Chenguang Biotech Group, a leading player in the biotechnology industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1992, the company has established itself as a pioneer in the development and production of high-quality biopharmaceuticals and agricultural products. Chenguang Biotech Group's core offerings include amino acids, organic acids, and other fermentation-derived products, which are distinguished by their purity and sustainability. The company has achieved significant milestones, including advancements in fermentation technology that enhance product efficacy. With a strong market position, Chenguang Biotech Group is recognised for its commitment to innovation and quality, making it a trusted partner in both the pharmaceutical and agricultural sectors. Its dedication to research and development continues to drive its success in the global market.
How does CHENGUANG BIOTECH GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CHENGUANG BIOTECH GROUP's score of 22 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chenguang Biotech Group, headquartered in China (CN), currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As of now, Chenguang Biotech Group does not inherit emissions data from any parent or related organizations, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing climate change or its carbon footprint. In the absence of concrete figures or commitments, it is essential for Chenguang Biotech Group to consider developing a comprehensive climate strategy that includes measurable targets and transparent reporting to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CHENGUANG BIOTECH GROUP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
